Urine proteomics in kidney transplantation

Transplantation Reviews

Volumn 28, Issue 1, 2014, Pages 15-20

  Kim, Steven C ^a   Page, Eugenia K ^a   Knechtle, Stuart J ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CD40 LIGAND; CREATININE; CXCL9 CHEMOKINE; CYSTATIN C; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 18; INTERLEUKIN 20; INTERLEUKIN 4; INTERLEUKIN 6; KIM 1 PROTEIN; MEMBRANE PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TIM 3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANTIBODY MEDIATED REJECTION; BK VIRUS INFECTION; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DELAYED GRAFT FUNCTION; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; MULTICENTER STUDY (TOPIC); NEPHROTOXICITY; PREDICTIVE VALUE; PROGNOSIS; PROTEOMICS; REVIEW; URINALYSIS; URINARY EXCRETION; URINE;

BIOLOGICAL MARKERS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROTEOMICS;

EID: 84889606051     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2013.10.004     Document Type: Review

References (32)

1. Bhangoo R.S., Hall I.E., Reese P.P., Parikh C.R. Deceased-donor kidney perfusate and urine biomarkers for kidney allograft outcomes : a systematic review. Nephrol Dial Transpl 2012, 27:3305-3314.
2. De Serres S.A., et al. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol 2012, 7:1018-1025.
3. Halawa A. The early diagnosis of acute renal graft dysfunction: A challenge we face. The role of novel biomarkers. Ann Transplant 2011, 16:90-98.
4. Hu H., Kwun J., Aizenstein B.D., Knechtle S.J. Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation 2009, 87:1814-1820.
5. Xu X., et al. Combination of IL-1 Receptor Antagonist, IL-20 and CD40 Ligand for the Prediction of Acute Cellular Renal Allograft Rejection. J Clin Immunol 2013, 33:280-287.
6. Matz M., Beyer J., Wunsch D., et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function. Kidney Int 2006, 69:1683-1690.
7. Lo D.J., Weaver T.A., Kleiner D.E., et al. Chemokines and their receptors in human renal allotransplantation. Transplantation 2011, 91:70-77.
8. Schaub S., Nickerson P., Rush D., et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant 2009, 9:1347-1353.
9. Ho J., Rush D.N., Karpinski M., et al. Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis. Transplantation 2011, 92:878-882.
10. Hirt-Minkowski P., Amico P., Ho J., et al. Detection of clinical and subclinical tubulo-interstitial inflammation by the urinary CXCL10 chemokine in a real-life setting. Am J Transplant 2012, 12:1811-1823.
11. Jackson J., Kim E.J., Begley B., et al. Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant 2011, 11:2228-2234.
12. Hricik D.E., Nickerson P., Formica R.N., et al. Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury. Am J Transplant 2013, 2634-2644. 10.1111/ajt.12426.
13. Suthanthiran M., Becker Y.T., Sharma V.K., et al. Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med 2013, 369:20-31.
14. Ho J., Rush D.N., Gibson I.W., et al. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts. Transplantation 2010, 90:394-400.
15. Ho J., Wiebe C., Rush D.N., et al. Increased urinary CCL2: Cr ratio at 6months is associated with late renal allograft loss. Transplantation 2013, 95:595-602.
16. Parikh C.R., Jani A., Mishra J., et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006, 6:1639-1645.
17. Hall I.E., Yarlagadda S.G., Coca S.G., et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol 2010, 21:189-197.
18. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 2010, 4:265-280.
19. Heyne N., Kemmner S., Schneider C., et al. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients. Transplantation 2012, 93:1252-1257.
20. Hall I.E., Koyner J.L., Doshi M.D., Marcus R.J., Parikh C.R. Urine cystatin C as a biomarker of proximal tubular function immediately after kidney transplantation. Am J Nephrol 2011, 33:407-413.
21. Leung-Tack J., Tavera C., Martinez J., Colle A. Neutrophil chemotactic activity is modulated by human cystatin c, an inhibitor of cysteine proteases. Inflammation 1990, 14.
22. Malheiro J., Fonseca I., Martins L.S., et al. A comparison between serum creatinine and cystatin C-based equations for estimation of graft function. Transplant Proc 2012, 44:2352-2356.
23. Mendiluce A., Bustamante J., Martin D., et al. Cystatin C as a marker of renal function in kidney transplant patients. Transplant Proc 2005, 37:3844-3847.
24. Nejat M., Hill J.V., Pickering J.W., et al. Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant 2012, 27:iii96-iii103.
25. Han W.K., Bailly V., Abichandani R., Thadhani R., Bonventre J.V. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002, 62:237-244.
26. Nogare A.L., et al. Quantitative analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction. Transplant Proc 2010, 42:473-474.
27. Nogare L., Dalpiaz T., Veronese F.J.V., Gonçalves L.F., Manfro R.C. Noninvasive analyses of kidney injury molecule-1 messenger RNA in kidney transplant recipients with graft dysfunction. Transplant Proc 2012, 44:2297-2299.
28. Van Timmeren M.M., Vaidya V.S., van Ree R.M., et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 2007, 84:1625-1630.
29. Ponciano V.C., Renesto P.G., Nogueira E., et al. Tim-3 expression in human kidney allografts. Transpl Immunol 2007, 17:215-222.
30. Manfro R.C., Aquino-Dias E.C., Joelsons G., et al. Noninvasive Tim-3 messenger RNA evaluation in renal transplant recipients with graft dysfunction. Transplantation 2008, 86:1869-1874.
31. Renesto P.G., Ponciano V.C., Cenedeze M.A., Saraiva Câmara N.O., Pacheco-Silva A. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant 2007, 7:1661-1665.
32. Almond P.S., Matas A., Gillingham K., et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993, 55:752-757.